AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JAN 30 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A Sendai virus-based HIV vaccine is effective when administered after a DNA prime, according to researchers in Japan.
"Heterologous prime/boost regimens are AIDS vaccine candidates because of their potential for inducing cellular immune responses," explained Tetsuro Matano and colleagues at the National Institute of Infectious Diseases' AIDS Research Center in Tokyo.
This strategy produced vigorous and persistent antiviral responses in animals, Matano and coauthors reported.
A cohort of rhesus macaques received a priming dose of env- and nef-deleted simian-human immunodeficiency virus (SHIV) proviral DNA, followed by a booster dose of recombinant Sendai virus expressing the HIV Gag protein. Animals treated with this regimen showed potent HIV specific T-cell activity, which lasted at least three months after inoculation, study data showed.
One week after challenge with the extremely virulent SHIV[subscript]89.6PD strain, vaccinated macaques displayed a vigorous and specific cytotoxic T-cell response not seen in vaccine-naive animals. Treated macaques did not suffer extensive CD4 cell loss after SHIV challenge, the researchers said, and maintained relatively low viral loads compared with their untreated counterparts.
Both components of the vaccine regimen induced specific cytotoxic T lymphocyte responses when given alone, but failed ...
Source: HighBeam Research, DNA Prime With Sendai Virus Booster Effective.(Brief Article)